Families caring for someone with Lewy body dementia need to track a specific constellation of symptoms and changes that distinguish this condition from other dementias. Unlike Alzheimer’s disease, which primarily affects memory first, Lewy body dementia involves progressive changes in movement, visual perception, sleep, and consciousness that appear alongside cognitive decline. The symptoms that matter most to track are motor changes (stiffness, tremor, slowness), visual hallucinations (seeing people or objects that aren’t there), unpredictable fluctuations in alertness and attention, and sleep disturbances—especially acting out dreams.
When someone with Lewy body dementia wakes up repeatedly at night or begins moving violently during sleep, that’s tracked information that helps doctors and caregivers understand disease progression and adjust care. Tracking these changes serves two critical purposes: it helps clinicians adjust medication and therapy, and it gives families an objective record of what’s actually happening rather than relying on memory or emotion in stressful moments. A caregiver might notice that their parent is more stiff on certain days, or that visual hallucinations get worse in dimly lit rooms, or that their alertness plummets in the late afternoon. These patterns, written down and brought to medical appointments, become the evidence that guides treatment decisions and helps the care team understand whether medications are helping or hurting.
Table of Contents
- What Motor and Movement Changes Should Families Track?
- Visual Hallucinations and Perceptual Disturbances in Lewy Body Dementia
- Monitoring Cognitive Fluctuations and Alertness Throughout the Day
- Tracking Sleep Disorders, REM Sleep Behavior Disorder, and Nighttime Changes
- Monitoring Medication Responses and Sensitivities
- Tracking Psychiatric and Behavioral Symptoms
- Establishing a Tracking System and Documenting Patterns
- Frequently Asked Questions
What Motor and Movement Changes Should Families Track?
Parkinsonism is one of the earliest signs families notice with lewy body dementia, and it’s critical to document these changes because they often appear before or alongside cognitive symptoms. Motor changes include rigidity (stiffness in the arms, legs, or neck), bradykinesia (slowness of movement), tremor at rest, and postural instability (difficulty with balance and walking). A family member might notice that a parent takes smaller steps, walks more slowly, or holds onto furniture more often. They might see tremors in the hands or notice that the person’s facial expression becomes more blank and unchanging—what’s called “masked facies.” These changes can progress rapidly, so tracking when each symptom first appeared and how it’s changed helps the medical team understand the disease trajectory. The challenge with tracking motor changes is distinguishing Lewy body dementia from Parkinson’s disease itself, which also causes these symptoms. In Lewy body dementia, parkinsonism often appears *after* cognitive changes or hallucinations begin, whereas in Parkinson’s disease, movement problems typically come first.
Families should note the order symptoms appeared and whether motor stiffness or tremor responds to Parkinson’s medications—in Lewy body dementia, these drugs often have minimal effect or can worsen other symptoms like hallucinations or confusion. One family documented that their father’s rigidity worsened each afternoon, peaked around 4 p.m., then improved by evening; that specific pattern helped his neurologist identify when medication doses needed adjusting. Falls and near-falls are also critical to track. As balance declines, the risk of injury rises sharply. Families should note how often falls occur, whether they happen in specific situations (like turning quickly or standing up), and whether the person catches themselves or goes down completely. Falls often accelerate care needs and hospitalizations, so documenting their frequency and circumstances is both a safety measure and important medical information.
Visual Hallucinations and Perceptual Disturbances in Lewy Body Dementia
Visual hallucinations are a defining feature of Lewy body dementia, appearing in about 80% of people with this condition. These aren’t vague or fleeting—families see their loved ones pointing at empty chairs and describing the person sitting there in detail, or becoming convinced that strangers are in the house, or watching animals that don’t exist. Unlike delusions where someone believes something false based on reasoning, hallucinations are sensory experiences: the person *sees* these things. Families need to track when hallucinations occur, what the person sees, how long they last, whether they cause distress, and what makes them better or worse. The context matters enormously for tracking. Hallucinations often worsen in low light, during evening hours (called “sundowning”), when the person is tired or stressed, or during infections.
One caregiver noticed their mother saw people in the hallway every evening around 5 p.m., but the hallucinations rarely happened in bright daylight. Another family documented that their father’s hallucinations involved children playing and farm animals, and these visions were actually comforting rather than frightening—so they didn’t try to “correct” him or argue that the animals weren’t real, which would only cause distress. Families should track not just *what* the person sees, but *how they feel* about it and whether the hallucination responds to environmental changes (turning on lights, moving to a different room) or medication adjustments. A critical warning: many antipsychotic medications commonly used for hallucinations in other conditions can be dangerous in Lewy body dementia. Drugs like haloperidol and risperidone can cause severe, sometimes life-threatening reactions in people with LBD, including neuroleptic sensitivity that leads to extreme stiffness, high fever, and rapid mental decline. Families must inform every doctor that their loved one has Lewy body dementia and must track any new symptoms after starting a psychiatric medication—increased confusion, severe stiffness, high fever, or drowsiness should trigger an immediate call to the neurologist.
Monitoring Cognitive Fluctuations and Alertness Throughout the Day
One of the most distinctive—and challenging—features of Lewy body dementia is that cognition and alertness fluctuate dramatically, sometimes hour to hour. A person might be alert and conversational in the morning, then become drowsy and confused by early afternoon, then perk up briefly at dinner. These aren’t subtle changes; families watch their loved one zone out mid-conversation, then become fully present again 20 minutes later. Tracking these patterns is essential because they help doctors distinguish Lewy body dementia from Alzheimer’s disease, where cognitive decline is usually more gradual and steady. Families should document the timing and severity of these fluctuations. Does confusion worsen at specific times of day? Does alertness dip after meals, after medications, or during certain activities? Is there a pattern to when the person is most responsive? One caregiver kept a daily log and discovered that their spouse was clearest between 8 and 11 a.m.
and after 4 p.m.—information that helped the family schedule important conversations and appointments during those windows and helped medical staff understand why the same person seemed competent one day and confused the next. Without this documentation, doctors might have misinterpreted the fluctuations as depression or medication side effects rather than recognizing them as the core feature of LBD. The unpredictability of these fluctuations also creates psychological stress for both the person with dementia and the family. A person with LBD might feel sharp one moment and disoriented the next, which can trigger anxiety or frustration. Families often struggle because they don’t know which version of their loved one will show up—the person who remembers conversations and cracks jokes, or the person who seems completely absent. Tracking these patterns helps families prepare emotionally and practically, and helps them communicate with medical teams about whether current medications are helping or contributing to the fluctuations.
Tracking Sleep Disorders, REM Sleep Behavior Disorder, and Nighttime Changes
Sleep disturbances are nearly universal in Lewy body dementia and can include multiple overlapping problems: insomnia, excessive daytime sleepiness, sleep apnea, and most distinctively, REM sleep behavior disorder (RBD). In RBD, the person loses the normal muscle paralysis that occurs during REM (dream) sleep, so they act out their dreams—sometimes violently. Families describe finding their loved one standing at the bedroom window at 2 a.m., or finding them on the floor after falling out of bed, or waking up struck or kicked during the night. Tracking these nighttime episodes is critical for safety and for medical diagnosis.
Families should document what specifically happens during sleep: Does the person wake up repeatedly? How many times per night? Do they cry out, thrash, or move violently? Do they fall out of bed or hurt themselves? Do they get up and wander, potentially putting themselves in danger? How alert are they when they wake—can they be reoriented, or are they confused and agitated? One family installed a camera in their father’s bedroom with his consent and discovered he was having 5-10 episodes per night of violent movements that the family had only partially witnessed. That documentation led to a sleep study diagnosis and medication that significantly improved nighttime safety. A limitation to understand: while medications like melatonin or low-dose clonazepam can help with RBD, they don’t cure the underlying sleep disorder, and adding sedating medications to someone with LBD can worsen daytime confusion and increase fall risk. This is a genuine tradeoff—families often must choose between accepting some nighttime disruption and accepting increased daytime confusion. Tracking the severity of both helps families and doctors make this decision.
Monitoring Medication Responses and Sensitivities
People with Lewy body dementia often have unusual or severe reactions to medications—a phenomenon called neuroleptic sensitivity or dopamine sensitivity. A dose of an antipsychotic that would be routine in another person can cause catastrophic reactions in someone with LBD: extreme stiffness, inability to move, high fever, altered consciousness, and even death in severe cases. Beyond antipsychotics, people with LBD can be sensitive to anticholinergic medications (drugs that block a neurotransmitter called acetylcholine), opioids, sedatives, and even some over-the-counter cold medicines. Families need to track what medications are being taken, when they were started, and what changes in symptoms or functioning occurred after starting them. If someone with LBD becomes suddenly more confused, more stiff, or more hallucinating after a new medication, this might be a side effect rather than disease progression.
One family’s father was prescribed a common antidepressant; within days he became so rigid he couldn’t get out of a chair, and the family didn’t initially connect it to the new medication because the stiffness seemed like LBD progression. When they mentioned the timeline to his neurologist, the medication was stopped and the stiffness resolved within a week. This is why families must track both medications and symptom changes—the sequence and timing reveal whether a change is the disease or the drugs. A critical warning: many medications prescribed by non-specialists—over-the-counter antihistamines, certain blood pressure drugs, anti-nausea medications—carry anticholinergic properties that can worsen cognitive symptoms and hallucinations in LBD. Families should ask every prescribing doctor, “Is this medication safe for someone with Lewy body dementia?” and provide written confirmation of the LBD diagnosis to all healthcare providers. When changes happen, families should ask whether a medication could be contributing before assuming it’s just the disease getting worse.
Tracking Psychiatric and Behavioral Symptoms
Lewy body dementia frequently includes depression, anxiety, apathy (lack of motivation or initiative), and personality changes that can be just as disabling as cognitive decline. A person might become withdrawn, lose interest in activities they once loved, become irritable with little provocation, or develop new fears or obsessions. These behavioral changes are tracked differently than motor or cognitive symptoms because they’re harder to measure objectively—there’s no “stiffness score” for depression—yet they significantly impact quality of life and family dynamics.
Families should document mood changes: Is the person withdrawn or talkative? Do they express sadness, hopelessness, or worthlessness? Have they lost interest in hobbies, food, socializing, or self-care? Do they express anxiety, fear, or worry? Have they become more irritable, aggressive, or impulsive? Changes in these areas help doctors distinguish between depression that might respond to antidepressants versus apathy that might require different approaches. One family noted that their mother stopped enjoying her garden and reading—activities she’d loved for decades—and became increasingly quiet. Initially they thought she was just declining, but when an antidepressant was started, she engaged again. Without tracking this behavioral shift, the depression might have been dismissed as inevitable disease progression.
Establishing a Tracking System and Documenting Patterns
The most useful tracking system is one families will actually use and one that captures information in a way doctors can understand. This doesn’t require sophisticated technology—a paper notebook or a simple spreadsheet works. What matters is consistency: recording observations at the same time each day or after specific events, and noting the date, time, what was observed, any potential triggers, and the context. Families might track: the time hallucinations occur and what triggers them, daily fluctuations in alertness (rating alertness on a scale of 1-10 at set times), sleep patterns (what time they went to bed, how many times they woke, what happened during sleep), motor symptoms (stiffness, tremor, falls), mood and behavior (withdrawn, irritable, engaged), and medication times and any changes noticed afterward.
Bringing this information to appointments, in writing, gives doctors concrete data rather than vague impressions. One family created a simple one-page chart showing the time of day on the x-axis and alertness level on the y-axis, with dots plotted for a week; it immediately showed their father’s pattern of morning clarity and afternoon decline, which helped adjust medication timing. Another family kept a log of hallucinations that documented: 3:47 p.m. Thursday—saw man in blue shirt in corner of room, looked frightened, lasted about 8 minutes, turned on lights and distraction helped. This specificity is far more useful than “has hallucinations.”.
Frequently Asked Questions
How often should we track symptoms?
Daily documentation is ideal, particularly for fluctuating symptoms like alertness and hallucinations. Even a quick evening note about the day helps build patterns. Motor symptoms and sleep can be tracked nightly; behavioral changes can be noted when they occur or seem significant.
What if we miss documenting some days?
Start again when you can. Consistency matters more than perfection. Even a partial record helps doctors see patterns and make better decisions about care and treatment.
How do we distinguish between Lewy body dementia progression and medication side effects?
Track the date medications start and note any symptom changes that occur in the following days or weeks. Rapid, dramatic changes—especially severe stiffness, high fever, or sudden confusion—are more likely medication reactions than gradual disease progression.
Should we correct the person when they’re hallucinating?
Research suggests arguing about hallucinations increases distress without changing the experience. Tracking whether hallucinations cause fear or comfort helps families decide whether to redirect attention (if distressing) or gently participate (if comforting).
Do we need to share all this tracking information with every doctor?
Yes—especially neurologists, but also primary care doctors, psychiatrists, and any specialists. Write a note: “Lewy body dementia diagnosed” at the top of all records. Include medication sensitivities prominently, as neuroleptic sensitivity is a safety issue.
What patterns should we watch for that might indicate a need to call the doctor immediately?
Call if you see sudden extreme stiffness, high fever with stiffness, severe increased confusion within days of a new medication, repeated falls, complete inability to sleep, or signs of infection (fever, urinary symptoms, confusion spike). These can indicate serious complications requiring urgent evaluation.
